MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/03913988211041639

Медицинская библиотека · The International journal of artificial organs · 2021

Association of thrombophilia prospective detection with hemocompatibility related outcomes in left ventricular assist device patients.

Konarik Miroslav, Netuka Ivan, Ivak Peter, Riha Hynek, Tucanova Zuzana, Wohlfahrt Peter, Maly Jiri, Szarszoi Ondrej

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Inherited thrombophilias represent a concerning risk factor due to a proclivity to an aberrant clot formation. However, in patients with left ventricular assist device (LVAD), their impact on bleeding and thrombotic complications remains still poorly understood. The aim of the present study was to evaluate the effect of thrombophilic mutation directed anticoagulation therapy on adverse clinical outcomes in LVAD patients.

MATERIALS AND

METHODS

About 138 consecutive patients indicated for LVAD implant (HeartMate II, Abbott, Plymouth, USA) were prospectively screened for three major thrombophilic mutations: factor II (prothrombin), factor V Leiden, and homozygous methylenetetrahydrofolate reductase (MTHFR). Subsequently, discordant individualized anticoagulation targets of INR 2.5-3.0 in thrombophilia positive and INR 1.8-2.2 in negative patients were established; notably without anti-platelet agents given the center standard of care.

RESULTS

Mean age was 50 ± 12.7 years, 83% male. Mean duration of support was 464.5 days (SD 482.9; SEM 41.1) and median of 310 days (IQR 162; 546). Full thrombophilia positive cohort analysis has not revealed any significant impact on event free survival. In contrast, detailed analysis of specific thrombophilias subsets has revealed Factor II prothrombin mutation as a significant predisposition for the pump thrombosis risk (SHR 10.48; p = 0.001) despite more aggressive prespecified anticoagulation target. Moreover, the incidence of bleeding events in prothrombin group was also significantly increased (SHR 6.0; p = 0.03).

CONCLUSIONS

Our observations suggest that specific thrombophilias in LVAD patients may pose different intensity predisposition for thrombotic complications. Factor II (prothrombin) positive mutation was identified as significant risk factor associated with the pump thrombosis.

Для цитирования: Konarik Miroslav, Netuka Ivan, Ivak Peter, Riha Hynek, Tucanova Zuzana, Wohlfahrt Peter, Maly Jiri, Szarszoi Ondrej. Association of thrombophilia prospective detection with hemocompatibility related outcomes in left ventricular assist device patients.. The International journal of artificial organs. 2021. DOI: 10.1177/03913988211041639.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.